Scientific Publications on Global Hepatitis B

These scientific publications are authored or co-authored by CDC scientists and/or funded by CDC’s Global Immunization Division, Center for Global Health.

2022

Assessing the impact of the routine childhood hepatitis B immunization program and the need for hepatitis B vaccine birth dose in Sierra Leone, 2018.
Breakwell L, Marke D, Kaiser R, et al. Vaccine. 2022;S0264-410X(22)00360-7. doi: 10.1016/j.vaccine.2022.03.049.

Progress Toward the Elimination of Mother-to-Child Transmission of Hepatitis B Virus — Worldwide, 2016–2021.
Khetsuriani N, Olufunmilayo L, Desai S, Armstrong PA, Tohme RA. MMWR Morb Mortal Wkly Rep. 2022; 71:958-963. doi: 10.15585/mmwr.mm7130a2

Progress towards the elimination of hepatitis B in children in Colombia: A novel two-phase study approach.
Ríos-Hincapié CY, Murad-Rivera R, Tohme RA, et al. J Viral Hepat. 2022. doi: 10.1111/jvh.13719.

2021

Progress toward hepatitis B control — World Health Organization European Region, 2016–2019.
Khetsuriani N, Mosina L, Van Damme P, Mozalevskis A, Datta S, Tohme RA. MMWR Morb Mortal Wkly Rep. 2021;70:1030-35. doi: 10.15585/mmwr.mm7030a1.

Seroprevalence of hepatitis B virus infection markers among children in Ukraine, 2017.
Khetsuriani N, Zaika O, Chitadze N, et al. Vaccine. 2021;39:1485-92. doi: 10.1016/j.vaccine.2021.02.004.

Hepatitis B surface antigen seroprevalence among children in the Philippines.
Minta AA, Silva MWT, Shrestha A, et al. Vaccine. 2021;39(14):1982-1989. doi: 10.1016/j.vaccine.2021.02.042.

2020

Seroprevalence of chronic hepatitis B virus infection and immunity to measles, rubella, tetanus and diphtheria among schoolchildren aged 6-7 years old in the Solomon Islands, 2016.
Breakwell L, Anga J, Cooley G, et al. Vaccine. 2020;38(30):4679-4686. doi: 10.1016/j.vaccine.2020.05.029.

An approach for preparing and responding to adverse events following immunization reported after hepatitis B vaccine birth dose administration.
Gidudu JF, Shaum A, Habersaat K, et al., Vaccine. 2020;38(49):7728-7740. doi: 10.1016/j.vaccine.2019.07.041.

Progress toward hepatitis B control — South-East Asia Region, 2016–2019.
Sandhu HS, Roesel S, Sharifuzzaman M, Chunsuttiwat S, Tohme RA. MMWR Morb Mortal Wkly Rep. 2020;69:988–992. doi: 10.15585/mmwr.mm6930a2.

Social and behavioral determinants of attitudes towards and practices of hepatitis B vaccine birth dose in Vietnam.
Thi Le XT, Ishizumi A, Thu Nguyen HT, et al. Vaccine. 2020;38(52):8343-8350. doi: 10.1016/j.vaccine.2020.11.009.

Evaluation of the efficiency of dried blood spot-based measurement of hepatitis B and hepatitis C virus seromarkers.
Yamamoto C, Nagashima S, Isomura M, et al. Sci Rep. 2020;10(1):3857. doi: 10.1038/s41598-020-60703-1.

2019

Prevalence of chronic hepatitis B virus infection among children in Haiti, 2017.
Childs L, Adrien P, Minta AA, et al. Am J Trop Med Hyg. 2019;101(1):214-219. doi: 10.4269/ajtmh.19-0117.

Hepatitis B surface antigen seroprevalence among pre- and post-vaccine cohorts in Cambodia, 2017.
Ork V, Woodring J, Shafiqul Hossain M, et al. Vaccine. 2019;37(35):5059-5066. doi: 10.1016/j.vaccine.2019.06.073.

Progress toward hepatitis B control and elimination of mother-to-child transmission of hepatitis B virus — Western Pacific Region, 2005–2017.
Woodring J, Pastore R, Brink A, Ishikawa N, Takashima Y, Tohme R. MMWR Morb Mortal Wkly Rep. 2019;68(8);195–200. doi: 10.15585/mmwr.mm6808a2.

Hepatitis B vaccination coverage among health care workers in China.
Yuan Q, Wang F, Zheng H, et al. PLoS One. 2019;14(5):e0216598. doi: 10.1371/journal.pone.0216598.

Integrated approach for triple elimination of mother-to-child transmission of HIV, hepatitis B and syphilis is highly effective and cost-effective: an economic evaluation.
Zhang L, Tao Y, Woodring J, et al. Int J Epidemiol. 2019;48(4):1327-1339. doi: 10.1093/ije/dyz037.

Selection From Previous Years

Hepatitis B vaccine birth dose coverage correlates worldwide with rates of institutional deliveries and skilled attendance at birth.
Allison RD, Patel MK, Tohme RA. Vaccine. 2017;35(33):4094-4098. doi: 10.1016/j.vaccine.2017.06.051.

Evaluation of storing hepatitis B vaccine outside the cold chain in the Solomon Islands: Identifying opportunities and barriers to implementation.
Breakwell L, Anga J, Dadari I, Sadr-Azodi N, Ogaoga D, Patel M. Vaccine. 2017;35(21):2770-2774. doi: 10.1016/j.vaccine.2017.04.011.

The status of hepatitis B control in the African Region.
Breakwell L, Tevi-Benissan C, Childs L, Mihigo R, Tohme R. Pan Afr Med J. 2017;27(Suppl 3):17. doi: 10.11604/pamj.supp.2017.27.3.11981.

Improving hepatitis B birth dose coverage through village health volunteer training and pregnant women education.
Li X, Heffelfinger J, Wiesen E, et al. Vaccine. 2017;35(34):4396-4401. doi: 10.1016/j.vaccine.2017.06.056.

Improving hepatitis B birth dose in rural Lao People’s Democratic Republic through the use of mobile phones to facilitate communication.
Xeuatvongsa A, Datta SS, Wannemuehler K, et al. Vaccine. 2016;34(47):5777-5784. doi: 10.1016/j.vaccine.2016.09.056.

https://www.cdc.gov/globalhealth/immunization/diseases/hepatitis-b/data/publications/index.html?fbclid=IwAR2p-E2JTjG2WOhYATzTu8RPq4XJ6w4JEdYIg4wAVzJ7gPEWjNyhLiWNbj4

Créditos: Comité científico Covid